CMND
Clearmind Medicine Inc.
NASDAQ · CAHealthcareBiotechnology
$1.87-3.61%
Price as of Jul 20, 2026
CMND valuation
Clearmind Medicine Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.66x
- Price / sales
- —
- Price / cash flow
- -2.82x
Enterprise value
- Enterprise value
- $5.5M
- EV / sales
- —
- EV / EBITDA
- -0.76x
- EV / EBIT
- -0.69x
- Market cap
- $19.1M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.